Americans favor reform – but not too much


Momentum is building in Washington to address numerous health care issues this year — namely, a prescription drug benefit in Medicare, managed care reform, and finding a way to address the problem of the uninsured. Certainly, there seems to be a mood in both parties to cooperate on several key pieces of legislation. For instance, Republicans now seem willing to support a pharmacy benefit in Medicare, while President Clinton has urged Congress to give the elderly a voluntary — not mandatory — opportunity to obtain such a benefit. Similar quiet resolve is evident on such issues as HMO liability and the uninsured.

Hand in hand with that resolve, though, is a feeling that whatever legislation is enacted will be watered down from the more far-reaching — and often polarizing — initiatives proposed in 1998 and 1999. This may be in sync with the sympathies of voters, whose desire for major change in health care seems only lukewarm this year.

The following responses are taken from a Kaiser Family Foundation/Harvard School of Public Health survey conducted in January. Responses are those of registered voters.

Career Opportunities

HAP, a subsidiary of Henry Ford Health System, is a nonprofit health plan providing coverage to individuals, companies and organizations. This executive develops strategies to meet membership and revenue targets through products, pricing, market segmentation and advertising.  Aligns business among Business Development, Commercial Sales, Medicare and Public Sector Programs and Product Development. Seeks to enhance and be responsible for business development and expansion through the development of an effective product portfolio, strong interpersonal relationships and service excellence.

Apply via email to jfedder1@hfhs.org or online at http://p.rfer.us/HENRYFORDlXqAJA

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.